Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy
Clinical trial NCT02680184 · COMPLETED
Trial details
- NCT number
- NCT02680184
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-12
- Primary completion
- 2022-12-06
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.